Sequence and structural basis for chromosomal fragility during translocations in cancer

Future Oncology

Volumn 8, Issue 9, 2012, Pages 1121-1134

  Gopalakrishnan, Vidya ^a   Raghavan, Sathees C ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

chromosomal abnormality; DNA damage; double strand break; genomic instability; nonhomologous DNA end joining

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CRUCIFORM DNA; DEAMINASE; DNA; DNA B;

CELL PROLIFERATION; CHROMATIN; CHROMATIN STRUCTURE; CHROMOSOME; CHROMOSOME ABERRATION; CHROMOSOME FRAGILITY; CHROMOSOME TRANSLOCATION; DNA CONFORMATION; DNA REPAIR; DNA SEQUENCE; DNA STRUCTURE; GENE FUSION; GENETIC DISORDER; GENOME; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BASE SEQUENCE; CHROMATIN; CHROMOSOME FRAGILITY; DNA DAMAGE; DNA REPAIR; GENOMIC INSTABILITY; HUMANS; NEOPLASMS; NUCLEIC ACID CONFORMATION; TRANSLOCATION, GENETIC;

EID: 84867045572     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.107     Document Type: Review

References (93)

1. Nambiar M, Kari V, Raghavan SC. Chromosomal translocations in cancer. Biochim. Biophys. Acta 1786(2), 139-152 (2008).
2. Nussenzweig A, Nussenzweig MC. Origin of chromosomal translocations in lymphoid cancer. Cell 141(1), 27-38 (2010).
3. Rabbitts TH. Chromosomal translocations in human cancer. Nature 372(6502), 143-149 (1994).
4. Ferguson DO, Alt FW. DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene 20(40), 5572-5579 (2001).
5. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science 132, 1497 (1960).
6. Warmuth M, Danhauser-Riedl S, Hallek M. Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies. Ann. Hematol. 78(2), 49-64 (1999).
7. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290-293 (1973).
8. Heisterkamp N, Stephenson JR, Groffen J et al. Localization of the c?ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 306(5940), 239-242 (1983).
9. Heisterkamp N, Stam K, Groffen J, de Klein A, Grosveld G. Structural organization of the bcr gene and its role in the Ph́ translocation. Nature 315(6022), 758-761 (1985).
10. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36(1), 93-99 (1984).
11. Sawyers CL. Molecular consequences of the BCR?ABL translocation in chronic myelogenous leukemia. Leuk. Lymphoma 11(Suppl. 2), 101-103 (1993).
12. Maru Y. Molecular biology of chronic myeloid leukemia. Int. J. Hematol. 73(3), 308-322 (2001).
13. Rabbitts TH, Forster A, Baer R, Hamlyn PH. Transcription enhancer identified near the human C mu immunoglobulin heavy chain gene is unavailable to the translocated c?myc gene in a Burkitt lymphoma. Nature 306(5945), 806-809 (1983).
14. Piccoli SP, Caimi PG, Cole MD. A conserved sequence at c?myc oncogene chromosomal translocation breakpoints in plasmacytomas. Nature 310(5975), 327-330 (1984).
15. Hollis GF, Mitchell KF, Battey J et al. A variant translocation places the lambda immunoglobulin genes 3́ to the c?myc oncogene in Burkitt's lymphoma. Nature 307(5953), 752-755 (1984).
16. Hamlyn PH, Rabbitts TH. Translocation joins c?myc and immunoglobulin gamma 1 genes in a Burkitt lymphoma revealing a third exon in the c?myc oncogene. Nature 304(5922), 135-139 (1983).
17. Raghavan SC, Lieber MR. DNA structures at chromosomal translocation sites. Bioessays 28(5), 480-494 (2006).
18. Bakhshi A, Jensen JP, Goldman P et al. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 36(1), 93-99 (1984).
19. Bakhshi A, Wright JJ, Graninger W et al. Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners. Proc. Natl Acad. Sci. USA 84(8), 2396-2400 (1987).
20. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl Acad. Sci. USA 82(21), 7439-7443 (1985).
21. Nambiar M, Raghavan SC. How does DNA break during chromosomal translocations? Nucleic Acids Res. 39(14), 5813-5825 (2011).
22. Prensner JR, Chinnaiyan AM. Oncogenic gene fusions in epithelial carcinomas. Curr. Opin Genet. Dev. 19(1), 82-91 (2009).
23. Tomlins SA, Rhodes DR, Perner S et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310(5748), 644-648 (2005).
24. Rabbitts TH. Commonality but diversity in cancer gene fusions. Cell 137(3), 391-395 (2009).
25. Tomlins SA, Laxman B, Varambally S et al. Role of the TMPRSS2?ERG gene fusion in prostate cancer. Neoplasia 10(2), 177-188 (2008).
26. Tognon C, Knezevich SR, Huntsman D et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2(5), 367-376 (2002).
27. Gordenin DA, Lobachev KS, Degtyareva NP, Malkova AL, Perkins E, Resnick MA. Inverted DNA repeats: a source of eukaryotic genomic instability. Mol. Cell. Biol. 13(9), 5315-5322 (1993).
28. Leach DR. Long DNA palindromes, cruciform structures, genetic instability and secondary structure repair. Bioessays 16(12), 893-900 (1994).
29. Collick A, Drew J, Penberth J et al. Instability of long inverted repeats within mouse transgenes. EMBO J. 15(5), 1163-1171 (1996).
30. Akgun E, Zahn J, Baumes S et al. Palindrome resolution and recombination in the mammalian germ line. Mol. Cell. Biol. 17(9), 5559-5570 (1997).
31. Inagaki H, Ohye T, Kogo H et al. Chromosomal instability mediated by non-B DNA: cruciform conformation and not DNA sequence is responsible for recurrent translocation in humans. Genome Res. 19(2), 191-198 (2009).
32. Fugmann SD, Lee AI, Shockett PE, Villey IJ, Schatz DG. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu. Rev. Immunol. 18, 495-527 (2000).
33. Lewis SM. The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses. Adv. Immunol. 56, 27-150 (1994).
34. Gellert M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 71, 101-132 (2002).
35. Swanson PC. The bounty of RAGs: recombination signal complexes and reaction outcomes. Immunol. Rev. 200, 90-114 (2004).
36. Jankovic M, Nussenzweig A, Nussenzweig MC. Antigen receptor diversification and chromosome translocations. Nat. Immunol. 8(8), 801-808 (2007).
37. Lieber MR, Yu K, Raghavan SC. Roles of nonhomologous DNA end joining, V(D)J recombination, and class switch recombination in chromosomal translocations. DNA Repair 5(9-10), 1234-1245 (2006).
38. Lieber MR, Raghavan SC, Yu K. Mechanistic aspects of lymphoid chromosomal translocations. J. Natl Cancer Inst. Monogr. 39, 8-11 (2008).
39. Raghavan SC, Kirsch IR, Lieber MR. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints. J. Biol Chem. 276(31), 29126-29133 (2001).
40. Lewis SM, Agard E, Suh S, Czyzyk L. Cryptic signals and the fidelity of V(D)J joining. Mol. Cell. Biol. 17, 3125-3136 (1997).
41. Zhang M, Swanson PC. V(D)J recombinase binding and cleavage of cryptic recombination signal sequences identified from lymphoid malignancies. J. Biol Chem. 283(11), 6717-6727 (2008).
42. Marculescu R, Le T, Simon P, Jaeger U, Nadel B. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites. J. Exp. Med. 195(1), 85-98 (2002).
43. Yoffe G, Schneider N, Van Dyk L et al. The chromosome translocation (11;14) (p13;q11) associated with T-cell acute lymphocytic leukemia: an 11p13 breakpoint cluster region. Blood 74(1), 374-379 (1989).
44. Muramatsu M, Sankaranand VS, Anant S et al. Specific expression of activationinduced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol Chem. 274(26), 18470-18476 (1999).
45. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102(5), 553-563 (2000).
46. Chaudhuri J, Alt FW. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 4(7), 541-552 (2004).
47. Papavasiliou FN, Schatz DG. Somatic hypermutation of immunoglobulin genes: merging mechanisms for genetic diversity. Cell 109(Suppl.), S35-S44 (2002).
48. Martin A, Scharff MD. AID and mismatch repair in antibody diversification. Nat. Rev. Immunol. 2(8), 605-614 (2002).
49. Larijani M, Martin A. Single-stranded DNA structure and positional context of the target cytidine determine the enzymatic efficiency of AID. Mol. Cell. Biol. 27(23), 8038-8048 (2007).
50. Stavnezer J, Guikema JE, Schrader CE. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26, 261-292 (2008).
51. Robbiani DF, Bothmer A, Callen E et al. AID is required for the chromosomal breaks in c?myc that lead to c?myc/IgH translocations. Cell 135(6), 1028-1038 (2008).
52. Okazaki IM, Kotani A, Honjo T. Role of AID in tumorigenesis. Adv. Immunol. 94, 245-273 (2007).
53. Callen E, Jankovic M, Difilippantonio S et al. ATM prevents the persistence and propagation of chromosome breaks in lymphocytes. Cell 130(1), 63-75 (2007).
54. Wang JH, Gostissa M, Yan CT et al. Mechanisms promoting translocations in editing and switching peripheral B cells. Nature 460(7252), 231-236 (2009).
55. Tsai AG, Lu H, Raghavan SC, Muschen M, Hsieh CL, Lieber MR. Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity. Cell 135(6), 1130-1142 (2008).
56. Schmutte C, Yang AS, Beart RW, Jones PA. Base excision repair of U:G mismatches at a mutational hotspot in the p53 gene is more efficient than base excision repair of T:G mismatches in extracts of human colon tumors. Cancer Res. 55(17), 3742-3746 (1995).
57. Frederico LA, Kunkel TA, Shaw BR. A sensitive genetic assay for the detection of cytosine deamination: determination of rate constants and the activation energy. Biochemistry 29(10), 2532-2537 (1990).
58. Tsai AG, Engelhart AE, Hatmal MM et al. Conformational variants of duplex DNA correlated with cytosine-rich chromosomal fragile sites. J. Biol Chem. 284(11), 7157-7164 (2009).
59. Raghavan SC, Swanson PC, Wu X, Hsieh CL, Lieber MR. A non-B?DNA structure at the Bcl?2 major breakpoint region is cleaved by the RAG complex. Nature 428(6978), 88-93 (2004).
60. Sinden RR. DNA Structure and Function. Academic Press, San Diego, CA, USA (1994).
61. Kogo H, Inagaki H, Ohye T, Kato T, Emanuel BS, Kurahashi H. Cruciform extrusion propensity of human translocation-mediating palindromic AT-rich repeats. Nucleic Acids Res. 35(4), 1198-1208 (2007).
62. Katapadi VK, Nambiar M, Raghavan SC. Potential G?quadruplex formation at breakpoint regions of chromosomal translocations in cancer may explain their fragility. Genomics 100(2), 72-80 (2012).
63. Frank-Kamenetskii MD, Mirkin SM. Triplex DNA structures. Annu. Rev. Biochem. 64, 65-95 (1995).
64. Soyfer VN, Potaman VN. Triple Helical Nucleic Acids. Spinger, NY, USA (1996).
65. Nambiar M, Goldsmith G, Moorthy BT et al. Formation of a G?quadruplex at the BCL2 major breakpoint region of the t(14;18) translocation in follicular lymphoma. Nucleic Acids Res. 39, 936-948 (2011).
66. Jager U, Bocskor S, Le T et al. Follicular lymphomas' BCL?2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation. Blood 95(11), 3520-3529 (2000).
67. Raghavan SC, Lieber MR. Chromosomal translocations and non-B DNA structures in the human genome. Cell Cycle 3(6), 762-768 (2004).
68. Kovalchuk AL, Muller JR, Janz S. Deletional remodeling of c?myc-deregulating chromosomal translocations. Oncogene 15(19), 2369-2377 (1997).
69. Li X, Manley JL. Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability. Cell 122(3), 365-378 (2005).
70. Yu K, Chedin F, Hsieh CL, Wilson TE, Lieber MR. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat. Immunol. 4(5), 442-451 (2003).
71. Shinkura R, Tian M, Smith M, Chua K, Fujiwara Y, Alt FW. The influence of transcriptional orientation on endogenous switch region function. Nat. Immunol. 4(5), 435-441 (2003).
72. Ramiro AR, Stavropoulos P, Jankovic M, Nussenzweig MC. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat. Immunol. 4(5), 452-456 (2003).
73. Tian M, Alt FW. Transcription-induced cleavage of immunoglobulin switch regions by nucleotide excision repair nucleases in vitro. J. Biol Chem. 275(31), 24163-24172 (2000).
74. Duquette ML, Pham P, Goodman MF, Maizels N. AID binds to transcriptioninduced structures in c?MYC that map to regions associated with translocation and hypermutation. Oncogene 24, 5791-5798 (2005).
75. Duquette ML, Handa P, Vincent JA, Taylor AF, Maizels N. Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA. Genes Dev. 18(13), 1618-1629 (2004).
76. Boveri T. Zur Frage der Entstehung maligner Tumoren. Gustav Fischer, Jena, Germany (1914).
77. Boyles JR, Bair MC, Campling BG, Jain N. Enhanced anti-cancer activities of some derivatives of titanocene dichloride. J. Inorg. Biochem. 84(1-2), 159-162 (2001).
78. Falk M, Lukasova E, Kozubek S. Higherorder chromatin structure in DSB induction, repair and misrepair. Mutat. Res. 704(1-3), 88-100 (2010).
79. Mani RS, Chinnaiyan AM. Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences. Nat. Rev. Genet. 11(12), 819-829 (2010).
80. Roix JJ, McQueen PG, Munson PJ, Parada LA, Misteli T. Spatial proximity of translocationprone gene loci in human lymphomas. Nat. Genet. 34(3), 287-291 (2003).
81. Mine-Hattab J, Rothstein R. Increased chromosome mobility facilitates homology search during recombination. Nat. Cell Biol. 4(5), 510-517 (2012).
82. Hakim O, Resch W, Yamane A et al. DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature 484(7392), 69-74 (2012).
83. Lin C, Yang L, Rosenfeld MG. Molecular logic underlying chromosomal translocations, random or non-random? Adv. Cancer Res. 113, 241-279 (2012).
84. Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 79, 181-211 (2010).
85. Deininger MW, Bose S, Gora-Tybor J, Yan XH, Goldman JM, Melo JV. Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation. Cancer Res. 58(3), 421-425 (1998).
86. Smith MA, McCaffrey RP, Karp JE. The secondary leukemias: challenges and research directions. J. Natl Cancer Inst. 88(7), 407-418 (1996).
87. Li X, Heyer WD. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. 18(1), 99-113 (2008).
88. Shinohara A, Ogawa T. Rad51/RecA protein families and the associated proteins in eukaryotes. Mutat. Res. 435(1), 13-21 (1999).
89. Pardo B, Gomez-Gonzalez B, Aguilera A. DNA repair in mammalian cells: DNA double-strand break repair: how to fix a broken relationship. Cell. Mol. Life Sci. 66(6), 1039-1056 (2009).
90. Richardson C, Jasin M. Frequent chromosomal translocations induced by DNA double-strand breaks. Nature 405(6787), 697-700 (2000).
91. Ferguson DO, Sekiguchi JM, Chang S et al. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc. Natl Acad. Sci. USA 97(12), 6630-6633 (2000).
92. Sallmyr A, Tomkinson AE, Rassool FV. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. Blood 112(4), 1413-1423 (2008).
93. Yan CT, Boboila C, Souza EK et al. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 449, 478-482 (2007).